{{ __('Your cart') }}0
0,00 $
0
items
0,00 $
Human Immunodeficiency Virus (HIV) is a virus that attacks the body's immune system, specifically targeting CD4+ T cells, which are crucial white blood cells that help fight infections. When HIV enters the body, it replicates itself and gradually weakens the immune system's ability to defend against infections and certain cancers. Without proper treatment, HIV can progress to Acquired Immunodeficiency Syndrome (AIDS), a condition where the immune system becomes severely compromised.
Early detection and prompt treatment of HIV are critical for maintaining good health and preventing transmission to others. When HIV is diagnosed and treated early, individuals can achieve an undetectable viral load, which means the virus cannot be transmitted to sexual partners. Regular testing is essential, especially for individuals at higher risk, as early-stage HIV often presents no symptoms.
Antiretroviral therapy (ART) is the standard treatment for HIV in Canada. ART involves taking a combination of HIV medicines daily to control the virus and prevent it from multiplying. These medications work by blocking different stages of the HIV life cycle, preventing the virus from replicating and allowing the immune system to recover and remain strong.
Thanks to advances in HIV treatment, people living with HIV in Canada can expect to live long, healthy lives when they adhere to their medication regimen. Modern ART can reduce the viral load to undetectable levels, allowing individuals to maintain strong immune systems, engage in normal activities, and have healthy relationships. Many people with HIV work, travel, exercise, and start families just like anyone else.
HIV prevention involves multiple strategies that significantly reduce transmission risk:
NRTIs are among the first HIV medications developed and remain a cornerstone of HIV treatment in Canada. These drugs work by blocking reverse transcriptase, an enzyme HIV needs to replicate itself. Common NRTIs available in Canada include zidovudine (AZT), emtricitabine (FTC), tenofovir, and abacavir. They are often combined with other drug classes to create highly effective treatment regimens.
NNRTIs also target the reverse transcriptase enzyme but work differently than NRTIs by binding directly to the enzyme and blocking its function. Canadian patients may be prescribed medications such as efavirenz, rilpivirine, or doravirine. These medications are frequently used in combination therapies and are known for their effectiveness in suppressing viral replication.
Protease inhibitors work by blocking the protease enzyme, which HIV needs to assemble new viral particles. This class of medications has been instrumental in transforming HIV from a fatal diagnosis to a manageable chronic condition. Common PIs available in Canada include darunavir, atazanavir, and lopinavir. Many protease inhibitors are boosted with ritonavir or cobicistat to enhance their effectiveness.
INSTIs represent one of the newest and most effective classes of HIV medications available in Canada. These drugs prevent HIV from integrating its genetic material into the host cell's DNA, effectively stopping viral replication. Popular INSTIs include dolutegravir, raltegravir, elvitegravir, and bictegravir. Many current first-line HIV treatment regimens in Canada include an INSTI due to their high efficacy and favourable side effect profiles.
Entry and fusion inhibitors work by preventing HIV from entering or fusing with CD4+ T cells. While less commonly used than other drug classes, they provide important treatment options for individuals with drug-resistant HIV or those who cannot tolerate other medications. Maraviroc, a CCR5 antagonist, and enfuvirtide, a fusion inhibitor, are examples of medications in this class available through Canadian healthcare providers for appropriate candidates.
Canada's healthcare system provides access to a comprehensive range of HIV medications through provincial drug plans and private insurance coverage. Health Canada has approved numerous antiretroviral therapies that effectively suppress the virus and help people with HIV maintain healthy, productive lives. These medications are available through licensed pharmacies across the country, with many patients accessing them through publicly funded programs.
Single-tablet regimens have revolutionized HIV treatment by combining multiple medications into one daily pill, significantly improving treatment adherence and quality of life for patients. The following combinations are widely prescribed across Canadian provinces:
Canadian HIV specialists also prescribe individual medications to create personalized treatment regimens tailored to patient-specific factors such as drug resistance patterns, comorbidities, and potential drug interactions. This approach allows healthcare providers to optimize therapy effectiveness while minimizing adverse effects, ensuring each patient receives the most appropriate treatment for their unique circumstances.
Pre-Exposure Prophylaxis (PrEP) is a daily medication taken by HIV-negative individuals to prevent HIV infection. PrEP is highly effective when taken consistently and is recommended for people at higher risk of HIV exposure. In Canada, healthcare providers may recommend PrEP for individuals who have an HIV-positive partner, engage in condomless sex with multiple partners, inject drugs, or work in high-risk occupational settings. A thorough risk assessment with a qualified healthcare provider is essential to determine if PrEP is appropriate for your situation.
Health Canada has approved several PrEP medications, with Truvada (emtricitabine/tenofovir disoproxil fumarate) being the most commonly prescribed option. Descovy (emtricitabine/tenofovir alafenamide) is another approved alternative that may be suitable for certain patients. These medications are available through prescription from qualified healthcare providers and can be dispensed at licensed pharmacies across Canada.
Post-Exposure Prophylaxis (PEP) is an emergency treatment that must be started within 72 hours of potential HIV exposure, ideally within 24 hours for maximum effectiveness. PEP typically involves a 28-day course of antiretroviral medications. If you believe you've been exposed to HIV, seek immediate medical attention at an emergency department, sexual health clinic, or contact your healthcare provider right away.
When taken consistently, PrEP reduces the risk of HIV infection by up to 99% for sexual transmission and up to 74% for injection drug use. For optimal protection, PrEP must be taken daily as prescribed. It takes approximately 7 days of consistent use to reach maximum protection levels for anal sex and up to 20 days for vaginal sex. Regular HIV testing and monitoring are required while taking PrEP.
Before starting PrEP or PEP, you must consult with a qualified healthcare provider who will conduct HIV testing, assess kidney function, screen for other sexually transmitted infections, and review your medical history. Regular follow-up appointments every three months are necessary to monitor your health, conduct HIV testing, and ensure the medication remains appropriate for your needs.
Consistent adherence to HIV treatment is crucial for maintaining an undetectable viral load and preventing the development of drug-resistant HIV strains. Taking medications exactly as prescribed helps ensure treatment effectiveness and reduces the risk of transmission to others. Modern HIV treatments are highly effective, and with proper adherence, most people with HIV can achieve and maintain an undetectable viral load, allowing them to live long, healthy lives.
While modern HIV medications are generally well-tolerated, some patients may experience side effects. Common side effects can include:
Most side effects are mild and may improve over time as your body adjusts to the medication. Your healthcare provider can recommend strategies to manage side effects or adjust your treatment regimen if necessary.
HIV medications can interact with other prescription drugs, over-the-counter medications, herbal supplements, and recreational substances. Always inform your healthcare provider and pharmacist about all medications and supplements you're taking. Some interactions can reduce the effectiveness of HIV treatment or increase the risk of side effects. Your pharmacy team can help identify potential interactions and provide guidance on timing medications appropriately.
Routine monitoring is essential for successful HIV treatment management. Regular blood tests help track your viral load, CD4 cell count, kidney and liver function, and overall health status. These tests typically occur every three to six months, depending on your treatment response and overall health. Consistent monitoring allows your healthcare team to make necessary adjustments to your treatment plan.
Maintaining a healthy lifestyle supports the effectiveness of HIV treatment and overall well-being. This includes eating a balanced diet, exercising regularly, avoiding smoking, limiting alcohol consumption, and managing stress. Some HIV medications should be taken with food, while others are best taken on an empty stomach. Your pharmacist can provide specific guidance on how to take your medications for optimal absorption and effectiveness.
HIV medications are covered through various provincial health insurance plans across Canada, though coverage details vary by province. Most provinces provide comprehensive coverage for approved HIV treatments through their public drug benefit programs. Private insurance plans may also provide coverage, and many patients benefit from a combination of public and private coverage to minimize out-of-pocket costs.
Pharmaceutical manufacturers offer patient assistance programs to help reduce the cost of HIV medications for eligible individuals. These programs may provide financial assistance, copay support, or free medication for qualifying patients. Additionally, community organizations and AIDS service organizations across Canada offer various support programs to help patients access treatment and navigate the healthcare system.
HIV medications require a prescription from a qualified healthcare provider, typically an infectious disease specialist, HIV specialist, or experienced family physician. Initial prescriptions often require consultation with an HIV specialist, though ongoing care may be managed by your family doctor in consultation with specialists. Some provinces have specific prescribing requirements or guidelines for HIV medications.
Licensed pharmacies across Canada can dispense HIV medications with appropriate prescriptions. Many pharmacies offer specialized services for HIV patients, including medication synchronization, adherence support, and confidential counselling. Pharmacists can provide valuable education about your medications, potential interactions, and proper storage requirements. Some pharmacies also offer home delivery services for added convenience and privacy.
Numerous resources are available across Canada to support individuals with HIV, including AIDS service organizations, community health centres, and online resources. The Canadian AIDS Treatment Information Exchange (CATIE) provides comprehensive, evidence-based information about HIV treatment and prevention. Provincial and local organizations offer support services, educational materials, and peer support programs to help individuals navigate their HIV care journey.
